Tracking cancer drugs in living cells by thermal profiling of the proteome
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Mapping human drug targets in the cell: To understand both the beneficial and the side effects of a drug, one would need to know its full binding profile to all cellular proteins. Savitski et al. take significant steps toward meeting this daunting challenge. They monitored the unfolding or “melting” of over 7000 human proteins and measured how small-molecule binding changes individual melting profiles. As a proof of principle, over 50 targets were identified for an inhibitor known to bind a broad spectrum of kinases. Two cancer drugs, vemurafib and Alectinib, are known to have a side effect of photosensitivity. The thermal profiling approach identified drug-protein interactions responsible for these side effects. Science , this issue 10.1126/science.1255784
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thermal proteome profiling (TPP, Savitski et al, 2014) is a mass-spectrometry (MS) based functional proteomics method that can identify shifts in protein thermal stability across different conditions (Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“Especially in combination with quantitative changes measured by e.g., phosphoproteomics, TPP can be used to identify functionally relevant alterations and link them to signaling and phenotypic consequences (Savitski et al, 2014; Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“TPP has been used successfully in the past for drug profiling, but it generates complex data that are difficult to interpret and potentially benefit from integration with other data types (Savitski et al, 2014; Perrin et al, 2020; Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“Thermal stabilization (i) is leveraged in thermal proteomics profiling (TPP), an approach that has been employed to, for instance, identify the ferrochelatase FECH as a frequent off-target of kinase inhibitors,224 or to uncover leucine aminopeptidase 3 as an off-target of several HDAC inhibitors.225”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [224]
In the citing paper
“This assay is based on the concept that binding of a compound to a protein can result in thermal stabilization of the protein and-consequently-in a detectable shift of its melting curve.”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as Savitski et al., 2014
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-48 · Cited by 3,356
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Self-citationDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Bollag, G., Hirth, P., Tsai, J., Zhang, J., Ibrahim, P. N., Cho, H., Spevak, W., Zhang, C., Zhang, Y., Habets, G., et al. (2010) · Nature · doi:10.1038/nature09454 · Cited by 1,831
Mass-spectrometry-based draft of the human proteome
Wilhelm, M., Schlegl, J., Hahne, H., Gholami, A. M., Lieberenz, M., Savitski, M. M., Ziegler, E., Butzmann, L., Gessulat, S., Marx, H., et al. (2014) · Nature · doi:10.1038/nature13319 · Cited by 1,820
Self-citationOverriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
Shah, N. P., Tran, C., Lee, F. Y., Chen, P., Norris, D., & Sawyers, C. L. (2004) · Science · doi:10.1126/science.1099480 · Cited by 1,796
Kulak, N. A., Pichler, G., Paron, I., Nagaraj, N., & Mann, M. (2014) · Nature Methods · doi:10.1038/nmeth.2834 · Cited by 1,719
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,034
Self-citation
Cited by
Items 201–300 of 1,004
CETSA in integrated proteomics studies of cellular processes
Prabhu, N., Dai, L., & Nordlund, P. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.11.004 · Cited by 63
Self-citationSabatier, P., Beusch, C. M., Gencheva, R., Cheng, Q., Zubarev, R. A., & Arnér, E. S. J. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102184 · Cited by 74
OPDA, more than just a jasmonate precursor
Jiménez‐Alemán, G. H., Thirumalaikumar, V. P., Jander, G., Fernie, A. R., & Skirycz, A. (2022) · Phytochemistry · doi:10.1016/j.phytochem.2022.113432 · Cited by 61
Galdeano, C., & Ciulli, A. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0059 · Cited by 59
Structural coverage of the proteome for pharmaceutical applications
Somody, J. C., MacKinnon, S. S., & Windemuth, A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.08.004 · Cited by 59
Van Vleet, T. R., Liguori, M. J., Lynch, III, Rao, M., & Warder, S. (2019) · SLAS Discovery · doi:10.1177/2472555218799713 · Cited by 59
DO-MS: Data-Driven Optimization of Mass Spectrometry Methods
Huffman, R. G., Chen, A., Specht, H., & Slavov, N. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00039 · Cited by 58
Hu, D., Yang, C., Lok, C., Xing, F., Lee, P., Fung, Y. M. E., Jiang, H., & Che, C. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201904131 · Cited by 59
Hit Triage and Validation in Phenotypic Screening: Considerations and Strategies
Vincent, F., Loria, P. M., Weston, A. D., Steppan, C. M., Doyonnas, R., Wang, Y., Rockwell, K. L., & Peakman, M. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.08.009 · Cited by 64
Characterizing Endogenous Protein Complexes with Biological Mass Spectrometry
Rogawski, R., & Sharon, M. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00217 · Cited by 62
Ferrochelatase is a therapeutic target for ocular neovascularization
Basavarajappa, H. D., Sulaiman, R. S., Qi, X., Shetty, T., Pasha, S. P. B. S., Sishtla, K. L., Lee, B., Quigley, J., Alkhairy, S., Briggs, C. M., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201606561 · Cited by 63
“…therapy: We have developed cremastranone analogs that may also act through FECH (Basavarajappa et al , 2015), and recently, the drugs vemu-rafenib (Savitski et al , 2014) and salicylic acid (Gupta et al , 2013), as well as a lipid-derived probe compound (Niphakis et al , 2015), were all shown to…”
Towards detecting regulatory protein–metabolite interactions
Diether, M., & Sauer, U. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.07.006 · Cited by 59
Why and How to Dig into Plant Metabolite–Protein Interactions
Venegas‐Molina, J., Molina‐Hidalgo, F. J., Clicque, E., & Goossens, A. (2021) · Trends in Plant Science · doi:10.1016/j.tplants.2020.12.008 · Cited by 63
Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer
Ryu, J., & Thomas, S. N. (2021) · Molecules · doi:10.3390/molecules26092674 · Cited by 66
Discovery of antibiotics that selectively kill metabolically dormant bacteria
Zheng, E. J., Valeri, J. A., Andrews, I. W., Krishnan, A., Bandyopadhyay, P., Anahtar, M. N., Herneisen, A. L., Schulte, F., Linnehan, B., Wong, F. J., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.10.026 · Cited by 62
“68,89 Finally, to assess the possibility that semapimod reacts pro-miscuously with intracellular protein targets, we used thermal proteome profiling (TPP), which identifies protein targets based on their differential heat stability after small molecule binding 38,90–92 (Figure S7A).”
MethodLi, J., Vranken, J. G. V., Paulo, J. A., Huttlin, E. L., & Gygi, S. P. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00063 · Cited by 64
Analytical methods for obtaining binding parameters of drug–protein interactions: A review
Wang, L., Zhang, W., Shao, Y., Zhang, D., Guo, G., & Wang, X. (2022) · Analytica Chimica Acta · doi:10.1016/j.aca.2022.340012 · Cited by 59
A Biologist's Field Guide to Multiplexed Quantitative Proteomics
Bakalarski, C. E., & Kirkpatrick, D. S. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o115.056986 · Cited by 56
“presence and absence of drug compounds (99).”
Next-generation proteomics faces new challenges in environmental biotechnology
Armengaud, J. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.02.025 · Cited by 58
Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer
Tailor, D., Resendez, A., Garcia-Marques, F. J., Pandrala, M., Going, C. C., Bermudez, A., Kumar, V., Rafat, M., Nambiar, D. K., Honkala, A. T., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.02.014 · Cited by 61
Luque-Martin, R., Angell, D. C., Kalxdorf, M., Bernard, S. G., Thompson, W., Eberl, H. C., Ashby, C. A., Freudenberg, J., Sharp, C. H., den Bossche, J. V., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001310 · Cited by 61
Petrovic, D., Slade, L., Paikopoulos, Y., D’Andrea, D., Savic, N., Stančić, A., Miljković, J. L., Vignane, T., Drekolia, M. K., Mladenović, D. R., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2024.12.008 · Cited by 63
Recent Advances in Mass Spectrometry-Based Bottom-Up Proteomics
Movassaghi, C. S., Sun, J., Jiang, Y., Turner, N. P., Chang, V. H.-S., Chung, N., Chen, R. J., Browne, E. N., Lin, C., Schweppe, D. K., et al. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c06750 · Cited by 63
Small Molecule Targeting of Specific BAF (mSWI/SNF) Complexes for HIV Latency Reversal
Marian, C., Stoszko, M., Wang, L., Leighty, M. W., Crignis, E. D., Maschinot, C. A., Gatchalian, J., Carter, B. C., Chowdhury, B., Hargreaves, D. C., et al. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.08.004 · Cited by 60
“To circumvent the need for a derivatized scaffold for target ID, we turned to CETSA, a cell-based technique (Savitski et al., 2014).”
MethodNagasawa, I., Muroi, M., Kawatani, M., Ohishi, T., Ohba, S., Kawada, M., & Osada, H. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.11.010 · Cited by 56
Towards a functional understanding of the plant metabolome
Kosmacz, M., Sokołowska, E., Bouzaa, S., & Skirycz, A. (2020) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2020.02.005 · Cited by 56
Drug discovery inspired by bioactive small molecules from nature
Kim, S., Lim, S.-W., & Choi, J. (2022) · Animal Cells and Systems · doi:10.1080/19768354.2022.2157480 · Cited by 61
“…the CETSA-MS and DARTS-MS platforms become more powerful, thus enabling the acquisition of protein–ligand interactome data, as well as the accompanying physiological changes in biological samples such as cell lysates, intact cells, as well as tissues (Savitski et al. 2014; Pai et al. 2015).”
BackgroundLegler, J., Zalko, D., Jourdan, F., Jacobs, M. N., Fromenty, B., Balaguer, P., Bourguet, W., Kos, V. M., Nadal, Á., Beausoleil, C., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103480 · Cited by 59
“This method has been successfully applied to study drug targets and off-targets [35,36], as well as for deciphering drug–target interaction [37,38] and defining specific mechanisms of action in very complex samples [39].”
MethodKurzawa, N., Becher, I., Sridharan, S., Franken, H., Mateus, A., Anders, S., Bantscheff, M., Huber, W., & Savitski, M. M. (2020) · Nature Communications · doi:10.1038/s41467-020-19529-8 · Cited by 53
Self-citationProteomics in the pharmaceutical and biotechnology industry: a look to the next decade
Lill, J. R., Mathews, W. R., Rose, C. M., & Schirle, M. (2021) · Expert Review of Proteomics · doi:10.1080/14789450.2021.1962300 · Cited by 59
High-throughput functional characterization of protein phosphorylation sites in yeast
Viéitez, C., Busby, B. P., Ochoa, D., Mateus, A., Memon, D., Galardini, M., Yildiz, U., Trovato, M., Jawed, A., Geiger, A. G., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01051-x · Cited by 52
Self-citationRgs16 promotes antitumor CD8 + T cell exhaustion
Weisshaar, N., Wu, J., Ming, Y., Madi, A., Hotz‐Wagenblatt, A., Ma, S., Mieg, A., Hering, M., Zettl, F., Möhr, K., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abh1873 · Cited by 57
Chemoproteomics, A Broad Avenue to Target Deconvolution
Gao, Y., Ma, M., Li, W., & Lei, X. (2023) · Advanced Science · doi:10.1002/advs.202305608 · Cited by 60
Trapping mammalian protein complexes in viral particles
Eyckerman, S., Titeca, K., Quickelberghe, E. V., Cloots, E., Verhee, A., Samyn, N., Ceuninck, L. D., Timmerman, E., Sutter, D. D., Lievens, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms11416 · Cited by 63
McNulty, D. E., Bonnette, W. G., Qi, H., Wang, L., Ho, T. F., Waszkiewicz, A., Kallal, L. A., Nagarajan, R. P., Stern, M., Quinn, A. M., et al. (2017) · SLAS DISCOVERY · doi:10.1177/2472555217732014 · Cited by 52
Türkowsky, D., Jehmlich, N., Diekert, G. B., Adrian, L., von Bergen�, M., & Goris, T. (2018) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiy013 · Cited by 58
A mass spectrometry-based proteome map of drug action in lung cancer cell lines
Ruprecht, B., Bernardo, J. D., Wang, Z., Mo, X., Ursu, O., Christopher, M., Fernandez, R. B., Zheng, L., Dill, B. D., Wang, H., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0572-3 · Cited by 61
Identification of phosphosites that alter protein thermal stability
Smith, I. R. L., Hess, K. N., Bakhtina, A. A., Valente, A. S., Rodríguez‐Mias, R. A., & Villén, J. (2021) · Nature Methods · doi:10.1038/s41592-021-01178-4 · Cited by 54
Xlink Mapping and AnalySis (XMAS) - Smooth Integrative Modeling in ChimeraX
Lagerwaard, I. M., Albanese, P., Jankevics, A., & Scheltema, R. A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.21.489026 · Cited by 52
“The technique has proved instrumental in uncovering relative quantities of proteins between different cellular states (5, 6, 7), location of post-translational modifications (6), melt curves of proteins (7, 8), location in cellular compartments (8, 9, 10), and many other details of the life of proteins inside and outs…”
BackgroundCheung, L. C., Aya‐Bonilla, C., Cruickshank, M. N., Chiu, S. K., Kuek, V., Anderson, D. R., Chua, G.-A., Singh, S., Oommen, J., Ferrari, E., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01746-3 · Cited by 54
“Upon binding of a small molecule to a protein the thermal stability and aggregation temperature of the target protein is altered, and this change in aggregation temperature can be detected by various means such as western blotting [24], AlphaScreen [26], and mass spectrometry [25, 27].”
BackgroundSelf-citationHomogeneous Assay for Target Engagement Utilizing Bioluminescent Thermal Shift
Dart, M. L., Machleidt, T., Jost, E., Schwinn, M. K., Robers, M. B., Shi, C., Kirkland, T. A., Killoran, M. P., Wilkinson, J., Hartnett, J. R., et al. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00081 · Cited by 60
Lim, Y. T., Prabhu, N., Dai, L., Go, K. D., Chen, D., Sreekumar, L., Egeblad, L., Eriksson, S., Chen, L., Veerappan, S., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0208273 · Cited by 52
“CETSA has previously been shown to give stringent data for higher affinity drug interactions [18].”
InfluentialSelf-citationDai, L., Li, Z., Chen, D., Jia, L., Guo, J., Zhao, T., & Nordlund, P. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107690 · Cited by 58
Self-citationJustice, J. L., Kennedy, M. A., Hutton, J. E., Liu, D., Song, B., Phelan, B., & Cristea, I. M. (2021) · Science Advances · doi:10.1126/sciadv.abg6680 · Cited by 57
Capturing dynamic protein interactions
Li, X., Chavali, P. L., & Babu, M. M. (2018) · Science · doi:10.1126/science.aat0576 · Cited by 52
Mapping protein–protein interactions by mass spectrometry
Liu, X., Abad, L., Chatterjee, L., Cristea, I. M., & Varjosalo, M. T. (2024) · Mass Spectrometry Reviews · doi:10.1002/mas.21887 · Cited by 64
“…PPI profiling methods have been developed, which include Co ‐ fractionation (CF), Thermal Proximity Coag-gregation (TPCA), and Ion ‐ Based Proteome ‐ Integrated Solubility Alteration (I ‐ PISA) (Figure 2) (Beusch et al., 2022; Kristensen et al., 2012; Savitski et al., 2014; Tan et al., 2018).”
Pan, S., Jang, S., Liew, S. S., Fu, J., Wang, D., Lee, J., & Yao, S. Q. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201710856 · Cited by 54
Tyr‐Asp inhibition of glyceraldehyde 3‐phosphate dehydrogenase affects plant redox metabolism
Moreno, J. C., Rojas, B. E., Vicente, R., Górka, M., Matz, T. W., Chodasiewicz, M., Peralta‐Ariza, J. S., Zhang, Y., Alseekh, S., Childs, D., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020106800 · Cited by 55
“Cell culture (for TPP) Cell suspension culture PSB-L of A. thaliana , derived from MM2d cells, was grown in MSMO medium, in a continuous photoperiod, at 21 ° C, on an orbital shaker (110 – 120 rpm).”
InfluentialAdvancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence
Duran-Frigola, M., Cigler, M., & Winter, G. E. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c11098 · Cited by 50
Heppler, L. N., Attarha, S., Persaud, R., Brown, J. I., Wang, P., Petrova, B., Tošić, I., Burton, F., Flamand, Y., Walker, S. R., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101531 · Cited by 49
“In PISA, T, temperature, is used as the agent inducing protein precipitation, whereas other agents are also possible, and the signal corresponds to the integral of a melting curve in TPP, regardless of its shape.”
BackgroundInfluentialProteomic characterization of post-translational modifications in drug discovery
Zhai, L., Chen, K., Hao, B., & Tan, M. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-01017-y · Cited by 59
“A novel technology named thermal proteome profiling (TPP) was developed to overcome these shortcomings [30, 31].”
BackgroundSmall-molecule dissolution of stress granules by redox modulation benefits ALS models
Uechi, H., Sridharan, S., Nijssen, J., Bilstein, J., Iglesias‐Artola, J. M., Kishigami, S., Casablancas-Antràs, V., Poser, I., Martinez, E. J., Boczek, E. E., et al. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-01893-5 · Cited by 152
“TPP was performed as described previously 34 .”
Self-citationLuzarowski, M., Vicente, R., Kiselev, A., Wagner, M. M., Schlossarek, D., Erban, A., de Souza, L. P., Childs, D., Wojciechowska, I., Luzarowska, U., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01684-3 · Cited by 50
Chana, C. K., Maisonneuve, P., Posternak, G., Grinberg, N. G. A., Poirson, J., Ona, S. M., Ceccarelli, D. F., Mader, P., St-Cyr, D. J., Pau, V., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00509 · Cited by 47
Improved Proteomics-Based Drug Mechanism-of-Action Studies Using 16-Plex Isobaric Mass Tags
Zinn, N., Werner, T., Doce, C., Mathieson, T., Boecker, C., Sweetman, G., Fufezan, C., & Bantscheff, M. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00900 · Cited by 49
Self-citationHow many kinases are druggable? A review of our current understanding
Anderson, B., Rosston, P., Ong, H. W., Hossain, M. A., Davis-Gilbert, Z. W., & Drewry, D. H. (2023) · Biochemical Journal · doi:10.1042/bcj20220217 · Cited by 47
Understanding the molecular diversity of synapses
van Oostrum, M., & Schuman, E. M. (2025) · Nature Reviews Neuroscience · doi:10.1038/s41583-024-00888-w · Cited by 49
Target Engagement Assays in Early Drug Discovery
John‐Campbell, S. S., & Bhalay, G. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c03115 · Cited by 66
Extending kinome coverage by analysis of kinase inhibitor broad profiling data
Jacoby, E., Tresadern, G., Bembenek, S. D., Wroblowski, B., Buyck, C., Neefs, J., Rassokhin, D. N., Poncelet, A., Hunt, J. P., & van Vlijmen, H. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.01.002 · Cited by 51
The resurgence of phenotypic screening in drug discovery and development
Wagner, B. K. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1122589 · Cited by 53
“stability of protein targets have great potential to provide information about a compound’s activity.[15] Beyond proteomics approaches, cell-based meth-”
BackgroundProteome-wide Analysis of Protein Thermal Stability in the Model Higher Plant Arabidopsis thaliana
Volkening, J. D., Stecker, K. E., & Sussman, M. R. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.001124 · Cited by 54
“Thermal Shifts Upon ATP Treatment—Using a broad-spectrum in vitro treatment, we have demonstrated the suitability of TPP for probing changes in plant protein stability upon perturbation, with Mg-ATP as a positive control as used previously in other organisms (4).”
BackgroundMethodInfluentialWang, Z., Liu, F., Ye, S., Jiang, P., Yu, X., Xu, J., Du, X., Ma, L., Cao, H., Yuan, C., et al. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.12.031 · Cited by 57
CETSA: A Target Engagement Assay with Potential to Transform Drug Discovery
Jensen, A. J., Molina, D. M., & Lundbäck, T. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.50 · Cited by 49
Self-citationDecrypting the molecular basis of cellular drug phenotypes by dose-resolved expression proteomics
Eckert, S., Berner, N., Kramer, K., Schneider, A., Müller, J., Lechner, S., Brajkovic, S., Sakhteman, A., Grätz, C., Fackler, J., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02218-y · Cited by 58
“This mechanism would be an elegant explanation for the observation that MTX also induces a very strong thermal or solvent stability shifts for DHFR when bound to MTX 12,13,15 .”
Quantitative, Real-Time Measurements of Intracellular Target Engagement Using Energy Transfer
Robers, M. B., Vasta, J. D., Corona, C. R., Ohana, R. F., Hurst, R., Jhala, M. A., Comess, K. M., & Wood, K. V. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8891-4_3 · Cited by 47
“The cellular thermal shift assay (CETSA) represents a significant advancement for cellular analysis, as it queries compound binding of endogenously expressed targets, using intact cells [1].”
BackgroundYuan, L., Wang, F.-Y., Levine, M. S., Shi, H.-R., Wang, Y., Xiong, X., Yang, L.-M., Shi, Y., Zou, T., Sessler, J. L., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c00255 · Cited by 50
Stern, A. M., Schurdak, M. E., Bahar, İ., Berg, J. M., & Taylor, D. L. (2016) · SLAS DISCOVERY · doi:10.1177/1087057116635818 · Cited by 50
Target Validation Using PROTACs: Applying the Four Pillars Framework
Nowak, R. P., & Jones, L. H. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220979584 · Cited by 51
Deep thermal profiling for detection of functional proteoform groups
Kurzawa, N., Leo, I. R., Stahl, M. M. S., Kunold, E., Becher, I., Audrey, A., Mermelekas, G., Huber, W. K., Mateus, A., Savitski, M. M., et al. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01284-8 · Cited by 50
Self-citationMedicinal Bioprospecting of the Amazon Rainforest: A Modern Eldorado?
Skirycz, A., Kierszniowska, S., Méret, M., Willmitzer, L., & Tzotzos, G. T. (2016) · Trends in biotechnology · doi:10.1016/j.tibtech.2016.03.006 · Cited by 55
An Unbiased Chemical Proteomics Method Identifies FabI as the Primary Target of 6-OH-BDE-47
Peng, H., Guo, H., Pogoutse, O., Wan, C., Hu, L. Z., Ni, Z., & Emili, A. (2016) · Environmental Science & Technology · doi:10.1021/acs.est.6b03541 · Cited by 51
An update of label-free protein target identification methods for natural active products
Cui, Z., Li, C., Chen, P., & Yang, H. (2022) · Theranostics · doi:10.7150/thno.68804 · Cited by 48
“By monitoring the effects of small-molecule ligands on the profiles, researchers delineated more than 50 targets for the kinase inhibitor staurosporine in the TPP assay, they identified the haem biosynthesis enzyme FECH as a target of kinase inhibitors and suggested that its inhibition caused the phototoxicity observe…”
BackgroundMethodInfluentialZhang, X., Wang, K., Wu, S., Ruan, C., Li, K., Wang, Y., Zhu, H., Liu, X., Liu, Z., Li, G., et al. (2022) · Chemical Science · doi:10.1039/d2sc03326g · Cited by 45
“S4 Number of total protein quantified by TPP-Savitski, pHDPP, in-house TPP and SIP approaches.”
MethodHering, M., Madi, A., Sandhoff, R., Ma, S., Wu, J., Mieg, A., Richter, K., Möhr, K., Knabe, N., Stichling, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50341-w · Cited by 49
Chernobrovkin, A. L., Marín‐Vicente, C., Visa, N., & Zubarev, R. A. (2015) · Scientific Reports · doi:10.1038/srep11176 · Cited by 53
Perspective on CETSA Literature: Toward More Quantitative Data Interpretation
Seashore-Ludlow, B. A., Axelsson, H., & Lundbäck, T. (2019) · SLAS DISCOVERY · doi:10.1177/2472555219884524 · Cited by 45
Tong, K., Wan, P., Lok, C., & Che, C. (2021) · Chemical Science · doi:10.1039/d1sc02841c · Cited by 46
Chemoproteomic profiling of protein–metabolite interactions
Qin, W., Yang, F., & Wang, C. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.11.003 · Cited by 46
Stein, B. D., Ferrarone, J. R., Gardner, E. E., Chang, J. W., Wu, D., Hollstein, P. E., Liang, R. J., Yuan, M., Chen, Q., Coukos, J. S., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0805 · Cited by 49
“Thermal proteome profiling was also used to measure the thermal stability of TPI1 proteoforms (41, 42).”
Veyel, D., Kierszniowska, S., Kosmacz, M., Sokołowska, E., Michaelis, A., Luzarowski, M., Szlachetko, J. A., Willmitzer, L., & Skirycz, A. (2017) · Scientific Reports · doi:10.1038/srep42387 · Cited by 44
Monitoring structural modulation of redox-sensitive proteins in cells with MS-CETSA
Sun, W., Dai, L., Yu, H., Puspita, B., Zhao, T., Li, F., Tan, J. L., Lim, Y. T., Chen, M. W., Sobota, R. M., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101168 · Cited by 43
“By combining the principles of CETSA and mass spectrometry (MS)-based quantitative proteomics, a more comprehensive assessment can be made regarding the stability effects on thousands of cellular proteins [19].”
MethodSelf-citationMonitoring protein communities and their responses to therapeutics
Budayeva, H. G., & Kirkpatrick, D. S. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0063-y · Cited by 45
Protein Folding Stability Changes Across the Proteome Reveal Targets of Cu Toxicity in E. coli
Wiebelhaus, N., Zaengle-Barone, J. M., Hwang, K. K., Franz, K. J., & Fitzgerald, M. C. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00900 · Cited by 50
Thermal Proteome Profiling Reveals the O-GlcNAc-Dependent Meltome
King, D. T., Serrano-Negrón, J. E., Zhu, Y., Moore, C. L., Shoulders, M. D., Foster, L. J., & Vocadlo, D. J. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.1c10621 · Cited by 46
Beusch, C. M., Sabatier, P., & Zubarev, R. A. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c00391 · Cited by 48
Braun, C. R., Bird, G. H., Wühr, M., Erickson, B. K., Rad, R., Walensky, L. D., Gygi, S. P., & Haas, W. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b02307 · Cited by 44
Innovations in improving lipid production: Algal chemical genetics
Wase, N., Black, P., & DiRusso, C. (2018) · Progress in Lipid Research · doi:10.1016/j.plipres.2018.07.001 · Cited by 43
Selkrig, J., Li, N., Hausmann, A., Mangan, M., Zietek, M., Mateus, A., Bobonis, J., Sueki, A., Imamura, H., Debs, B. E., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0736-7 · Cited by 53
Self-citationNatural-Product-Based Solutions for Tropical Infectious Diseases
Adegboye, O., Field, M. A., Kupz, A., Pai, S., Sharma, D., Smout, M. J., Wangchuk, P., Wong, Y., & Loiseau, C. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00348-20 · Cited by 50
Sabatier, P., Beusch, C. M., Saei, A. A., Aoun, M., Moruzzi, N., Coelho, A., Leijten, N. M., Nordenskjöld, M., Micke, P., Maltseva, D. V., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26879-4 · Cited by 46
Matrix Thermal Shift Assay for Fast Construction of Multidimensional Ligand–Target Space
Ruan, C., Wang, Y., Zhang, X., Lyu, J., Zhang, N., Ma, Y., Shi, C., Qu, G., & Ye, M. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c04627 · Cited by 41
Gaetani, M., & Zubarev, R. A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2624-5_7 · Cited by 47
Learning deep representations of enzyme thermal adaptation
Li, G., Buric, F., Zrimec, J., Viknander, S., Nielsen, J., Zelezniak, A., & Engqvist, M. K. M. (2022) · Protein Science · doi:10.1002/pro.4480 · Cited by 42
“Understanding temperature effects on proteins is also fundamental to basic biology 5,7,8 , drug discovery 9 and protein engineering 10 .”
BackgroundGenetic code expansion reveals site-specific lactylation in living cells reshapes protein functions
Shao, C., Tang, S., Yu, S., Liu, C., Zhang, Y., Wan, T., He, Z., Yuan, Q., Wu, S., Zhang, H., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55165-2 · Cited by 53
“The resultant band intensities of the Flag-tagged ALDOA were normalized to the intensity of the unheated group and fi tted to the Boltzmann sigmoid equation using Prism v.8.0.1 (GraphPad software) 68 .”
InfluentialDetection of Chemical Engagement of Solute Carrier Proteins by a Cellular Thermal Shift Assay
Hashimoto, M., Girardi, E., Eichner, R., & Superti‐Furga, G. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00270 · Cited by 47
Glycolytic flux-signaling controls mouse embryo mesoderm development
Miyazawa, H., Snaebjornsson, M. T., Prior, N., Kafkia, E., Hammarén, H. M., Tsuchida-Straeten, N., Patil, K. R., Beck, M., & Aulehla, A. (2022) · eLife · doi:10.7554/elife.83299 · Cited by 43
Hyperthermia Selectively Destabilizes Oncogenic Fusion Proteins
Maimaitiyiming, Y., Wang, Q. Q., Yang, C., Ogra, Y., Lou, Y., Smith, C. A., Hussain, L., Shao, Y., Lin, J., Liu, J., et al. (2021) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-20-0188 · Cited by 41
“First, P/R is relatively large (∼130 kDa), and larger proteins tend to be less thermally stable (14).”
BackgroundReal-Time Biological Annotation of Synthetic Compounds
Gerry, C. J., Hua, B. K., Wawer, M. J., Knowles, J. P., Nelson, S. D., Verho, O., Dandapani, S., Wagner, B. K., Clemons, P. A., Booker‐Milburn, K. I., et al. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b04614 · Cited by 49
Emerging strategies for the identification of protein–metabolite interactions
Luzarowski, M., & Skirycz, A. (2019) · Journal of Experimental Botany · doi:10.1093/jxb/erz228 · Cited by 41
“, 2013; Geer and Fitzgerald, 2016), thermal stability [cellular thermal shift assay (CETSA)/thermal proteome profiling (TPP)] (Martinez Molina et al., 2013; Savitski et al., 2014; Reckzeh et al., 2019), or susceptibility to proteolysis [drug affinity responsive target stability (DARTS)/limited proteolysis–small-molecu…”
BackgroundModification-free approaches to screen drug targets at proteome level
Lyu, J., Wang, K., & Ye, M. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.06.024 · Cited by 43
Metadata
- Authors
- Savitski, M. M., Reinhard, F. B. M., Franken, H., Werner, T., Savitski, M. F., Eberhard, D., Molina, D. M., Jafari, R., Dovega, R. B., Klaeger, S., Kuster, B., Nordlund, P., Bantscheff, M., & Drewes, G.
- Affiliations
- GlaxoSmithKline (Germany) (DE)
- Karolinska Institutet (SE)
- German Cancer Research Center (DE)
- Department of Proteomics and Bioanalytics, Technische Universität München, Emil Erlenmeyer Forum 5, Freising, Germany.
- Division of Biophysics, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
- Corresponding author
- Savitski, Mikhail M.
- Reinhard, Friedrich B. M.
- Bantscheff, Marcus
- Drewes, Gerard
- ORCID
- Venue
- Science
- Published
- 2014-10-03
- Volume
- 346
- Issue
- 6205
- Pages
- 1255784-1255784
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2131321938
- Cited by
- 1,187
- References
- 41
- Citations by year
- 2026: 119 · 2025: 138 · 2024: 148 · 2023: 130 · 2022: 116 · 2021: 132 · 2020: 95 · 2019: 85 · 2018: 67 · 2017: 56 · 2016: 54 · 2015: 39 · 2014: 5
- FWCI
- 22.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Physical Sciences › Chemistry › Physical and Theoretical Chemistry › thermodynamics and calorimetric analyses
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Keywords
- thermal proteome profiling, drug-target engagement, protein thermal stability, kinase inhibitors, staurosporine, ferrochelatase, vemurafenib, alectinib, phototoxicity, dasatinib, BCR-ABL, cancer drug targets
- MeSH terms
- Adenosine Triphosphatases, Antineoplastic Agents, Hot Temperature, Humans, Ligands, Protein Binding, Protein Denaturation, K562 Cells, Proteome, Proteomics, Protein Stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.